Article
Teva hires ex-Novartis executive to succeed CEO Schultz
Rating:
0.0
Views:
105
Likes:
1
Library:
1
Teva Pharmaceutical on Monday appointed former Novartis and Biogen executive Richard Francis to succeed chief executive officer Kare Schultz who is due to retire later this year.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value